Work

Afatinib followed by osimertinib in patients with EGFR mutation-positive (EGFRm+) advanced NSCLC: Updated data from the GioTag real-world study

Year: 2019

Type: article

Study design: Observational Study

Source: Annals of Oncology

DOI: 10.1093/annonc/mdz260.054

Authors: M.J. Hochmair, A. Morabito, D. Hao, C.-T. Yang, R. Soo, J C-H Yang, R. Gucalp, B. Halmos, L. Wang, A. Golembesky, A. Märten, T. Cufer

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2978854237

FWCI:

Cites:

Cited by: 1

Related to: 10